Aimed Bio Inc. · KRX:0009K0

Aimed Bio Inc. financial statements

Aimed Bio Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in KRW

Income statement

LineFY2025FY2024
Revenue47.3B11.8B
Gross profit47.3B11.8B
Selling, general and administrative19.5B7.53B
Operating income20.8B-407.8M
Depreciation and amortization1.38B1.46B
EBITDA22.2B1.06B
Interest expense57.0M93.1M
Income before tax-4.16B-3.31B
Net income5.02B-3.30B
Earnings per share, basic78.29-51.50

Balance sheet

LineFY2025FY2024
Cash and equivalents106.4B4.49B
Short-term investments64.4B31.0B
Receivables3.30B
Current assets178.5B36.2B
Total assets199.0B47.1B
Current liabilities5.68B43.6B
Total liabilities6.40B43.8B
Shareholders' equity192.6B3.36B
Shares outstanding64.2M64.2M

Cash flow

LineFY2025FY2024
Cash from operations17.9B-4.87B
Capital spending-362.6M-1.68B
Free cash flow17.5B-6.55B
Change in cash101.9B3.03B